Basic Information
Basic information for AP000289.1-202-114aa
Peptide Name AP000289.1-202-114aa
Genome Position chr21:33110867-33111061,33114516-33114623,33122247-33122285[-]
Species Human
Peptide Sequence MEEEPRKKWKHYPKEEADLWAFQKLQFWDLGENWSAWLPNRHNGSLQDQAWILILLPLCEARRELSAQYSVPHPHHIAASHSHQEKWGLSAAARRNSETSHFISGRIGSAPVWC
Peptide Length 114
Unique Yes
Grand Average of Hydropathicity -0.736
Relative Molecular Mass 15355.55
Experimental Evidences no
lncRNA ID/Name ENSG00000226527;AP000289.1
Transcript ID/Name ENST00000657804;AP000289.1-202
Transcript Length 2264
Coding Ability 0.6497
DNA Sequence Corresponding to Peptide ATGGAAGAGGAACCCAGAAAGAAATGGAAACACTATCCGAAGGAAGAGGCTGATCTTTGGGCTTTCCAAAAGCTGCAGTTCTGGGACCTGGGGGAAAATTGGAGTGCCTGGCTTCCAAACAGGCATAATGGCTCTCTGCAAGACCAAGCTTGGATTTTGATTTTGCTTCCTTTATGTGAAGCCAGGAGAGAGCTTAGCGCCCAGTACTCCGTGCCCCACCCCCACCACATCGCAGCCTCCCACAGTCACCAGGAAAAGTGGGGGCTTTCAGCGGCAGCCAGAAGGAATTCAGAAACATCACATTTCATTTCGGGAAGAATTGGATCAGCACCAGTTTGGTGT
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :